Accelerated radiotherapy for T1 to T2 glottic cancer. Issue 4 (10th April 2014)

• Record Type: Journal Article
• Authors: Motegi, Atsushi; Kawashima, Mitsuhiko; Arahira, Satoko; Zenda, Sadamoto; Toshima, Masamichi; Onozawa, Masakatsu; Hayashi, Ryuichi; Akimoto, Tetsuo
• Is Part Of: Head & neck. Volume 37:Issue 4(2015:Apr.)
• Page Start: 579
• Page End: 584
• Publication Date: 2014-04-10
• Subjects: early glottic cancer -- accelerated fractionation radiotherapy -- local control -- laryngeal preservation -- adverse events; Head -- Diseases -- Periodicals; Neck -- Diseases -- Periodicals; Head -- Periodicals; Neck -- Periodicals; Face -- Periodicals; 617.51059
• DOI: 10.1002/hed.23641
• Languages: English
• ISSNs: 1043-3074

Abstract

Abstract: Background: Accelerated fractionation radiotherapy (RT) was administered in an attempt to improve the local control rates in patients with T1/T2 N0 glottic cancer. Methods: Medical charts of 148 consecutive patients who had undergone RT using 2.4 Gray (Gy) once‐daily fractionation between July 1999 and April 2007 were reviewed. Results: Of 104 patients with T1 disease treated by RT, 82 received 60 Gy/25 fractions, and the remaining 22 with large tumor volumes and/or slow response to RT received 64.8 Gy/27 fractions. All 44 patients with T2 disease received 64.8 Gy/27 fractions. The 5‐year local control and overall survival (OS) rates were 93% and 96%, respectively, in patients with T1 disease, and 77% and 91%, respectively, in patients with T2 disease. No severe acute toxicities were observed, although 2 patients (1%) developed severe late toxicity. Conclusion: Accelerated RT for early glottic cancer is feasible, with encouraging local control rates. © 2014 Wiley Periodicals, Inc. Head Neck 37 : 579–584, 2015